ETV2 mediated differentiation of human pluripotent stem cells results in functional endothelial cells for engineering advanced vascularized microphysiological models
Shun ZhangiD, Zhengpeng WaniD, Lei WangiD, Caihong Wu, Junkai ZhangiD, Sarah SpitziD, Xun S WangiD, Marie A. FloryaniD, Mark F. CoughliniD, Francesca Michela PramottoniD, Liling XuiD, Ron WeissiD, Roger Dale KammiD
Abstract
Patient-specific microphysiological models, exemplified by organs-on-a-chip and organoids, have become a valuable tool for broad applications, revolutionizing biomedical research. However, limitations persist, with functional vasculature being a significant challenge. Generating functional human induced pluripotent stem cell (h-iPSC) derived endothelial cells (h-iECs) represent an urgent need. With the discovery of ETV2s determinant role in specifying EC lineages during differentiation, researchers have adopted techniques involving ETV2 overexpression to produce h-iECs more efficiently and consistently. However, the capacity of these cells to form functional vasculatures has not yet been thoroughly investigated. Here, we generated multiple h-iPSC lines with inducible ETV2 expression, and subsequently differentiated them into h-iECs, which were validated functionally and by key endothelial markers and RNA-seq analysis. These cells are capable of self-organizing into stable microvascular networks (MVNs) in a microfluidic chip reproducibly, forming lumenized and functional vessels that mimic the in vivo capillary bed in both morphology and function - a result not achieved using h-iECs differentiated with conventional two-step methods using the same h-iPSC lines. Furthermore, complex microphysiological models featuring perfusable vasculature were also successfully developed using ETV2 activated h-iECs, demonstrated with vascularized tumor and blood-brain barrier (BBB) models. Additionally, by pooling genetically engineered h-iPSCs with inducible ETV2, we effectively employed an orthogonally induced differentiation approach to enhance vascularization of an organoid model. Our methodology opens avenues in precision medicine, leading to personalized microphysiological models with perfusable vasculature for various applications.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- FWCI
- 8.21
- Field percentile
- top 2%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Robust differentiation of human pluripotent stem cells into endothelial cells via temporal modulation of ETV2 with modified mRNA
K. Wang, R.-Z. Lin, … J. Melero-Martin·bioRxiv·Mar 2, 2020
- High-Purity Production of Endothelial Cells from Human Pluripotent Stem Cells
Koki Yoshimoto, Ririka Okaichi, … Ken‐ichiro Kamei·Cell Therapy & Engineering ConnectPeer-reviewed·Oct 21, 2025
- Comparative methods for iPSC-Derived endothelial cells in modeling vascular diseases.
Pakize Nur Akkaya, Louet Koolen, Zohreh Hosseinzadeh·bioRxiv·Aug 21, 2026
- Human iPSC-derived mesodermal progenitor cells preserve their vasculogenesis potential after extrusion and form hierarchically organized blood vessels
L. Dogan, R. Scheuring, … S. Erguen·bioRxiv·May 9, 2021
- Tissue microenvironment dictates the state of human induced pluripotent stem cell-derived endothelial cells of distinct developmental origin in 3D cardiac microtissues
Xu Cao, Maria Mircea, … Valeria V. Orlova·bioRxiv·Nov 22, 2022
- Development of a human heart-on-a-chip model using induced pluripotent stem cells, fibroblasts and endothelial cells
Yun Liu, Rumaisa Kamran, … Ken Takahashi·Scientific ReportsPeer-reviewed·Aug 8, 2024